- Home
- NEO vs GAM Comparison
NEO vs GAM Comparison
Compare NEO & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- GAM
- Stock Information
- Founded
- NEO 2001
- GAM 1927
- Country
- NEO United States
- GAM United States
- Employees
- NEO N/A
- GAM N/A
- Industry
- NEO Precision Instruments
- GAM Investment Managers
- Sector
- NEO Health Care
- GAM Finance
- Exchange
- NEO Nasdaq
- GAM Nasdaq
- Market Cap
- NEO 965.2M
- GAM 1.2B
- IPO Year
- NEO 1999
- GAM N/A
- Fundamental
- Price
- NEO $7.00
- GAM $53.90
- Analyst Decision
- NEO Buy
- GAM
- Analyst Count
- NEO 9
- GAM 0
- Target Price
- NEO $13.31
- GAM N/A
- AVG Volume (30 Days)
- NEO 2.0M
- GAM 20.1K
- Earning Date
- NEO 07-28-2025
- GAM 01-01-0001
- Dividend Yield
- NEO N/A
- GAM 5.74%
- EPS Growth
- NEO N/A
- GAM N/A
- EPS
- NEO N/A
- GAM 11.67
- Revenue
- NEO $672,361,000.00
- GAM N/A
- Revenue This Year
- NEO $13.97
- GAM N/A
- Revenue Next Year
- NEO $11.36
- GAM N/A
- P/E Ratio
- NEO N/A
- GAM $3.95
- Revenue Growth
- NEO 10.10
- GAM N/A
- 52 Week Low
- NEO $6.08
- GAM $37.32
- 52 Week High
- NEO $19.12
- GAM $46.48
- Technical
- Relative Strength Index (RSI)
- NEO 40.74
- GAM 52.34
- Support Level
- NEO $6.90
- GAM $54.35
- Resistance Level
- NEO $7.42
- GAM $55.31
- Average True Range (ATR)
- NEO 0.39
- GAM 0.52
- MACD
- NEO -0.00
- GAM -0.19
- Stochastic Oscillator
- NEO 13.01
- GAM 7.84
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.